Margaret T. Kasner, MD

Articles by Margaret T. Kasner, MD

Current Classifications of Acute Myeloid Leukemia

ByJorge E. Cortes, MD,Brian Andrew Jonas, MD, PhD,Margaret T. Kasner, MD,Hetty Carraway, MD

January 24th 2023

Expert perspectives on current classification strategies in acute myeloid leukemia and how these guidelines make use of molecular markers.

Overview of Acute Myeloid Leukemia

ByJorge E. Cortes, MD,Brian Andrew Jonas, MD, PhD,Hetty Carraway, MD,Margaret T. Kasner, MD

January 24th 2023

Opening their discussion on the management of acute myeloid leukemia (AML), expert oncologists provide an overview on the incidence, diagnosis, and stratification of patients.

Margaret T. Kasner, MD

Articles by Margaret T. Kasner, MD

Current Classifications of Acute Myeloid Leukemia

Overview of Acute Myeloid Leukemia

Trending on OncLive

Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma

FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL

Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma

Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma

FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care